189 related articles for article (PubMed ID: 36125263)
21. Metformin and Trehalose-Modulated Autophagy Exerts a Neurotherapeutic Effect on Parkinson's Disease.
Gopar-Cuevas Y; Saucedo-Cardenas O; Loera-Arias MJ; Montes-de-Oca-Luna R; Rodriguez-Rocha H; Garcia-Garcia A
Mol Neurobiol; 2023 Dec; 60(12):7253-7273. PubMed ID: 37542649
[TBL] [Abstract][Full Text] [Related]
22. Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance.
Giordo R; Posadino AM; Mangoni AA; Pintus G
Biochem Pharmacol; 2023 Sep; 215():115732. PubMed ID: 37541452
[TBL] [Abstract][Full Text] [Related]
23. Implementation and assessment of a novel drug interaction tool (TLC-act) in an entry-to-practice doctor of pharmacy program.
Dahri K; Hong C; Yang C; Chan F
Curr Pharm Teach Learn; 2023 Sep; 15(9):836-842. PubMed ID: 37537006
[TBL] [Abstract][Full Text] [Related]
24. Effect of Metformin Use on Survival and Recurrence Rate of Gastric Cancer After Gastrectomy in Diabetic Patients: A Systematic Review and Meta-analysis of Observational Studies.
Bahardoust M; Mousavi S; Moezi ZD; Yarali M; Tayebi A; Olamaeian F; Tizmaghz A
J Gastrointest Cancer; 2024 Mar; 55(1):65-76. PubMed ID: 37526857
[TBL] [Abstract][Full Text] [Related]
25. Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus.
Oktora MP; de Vos S; de Vries ST; Hak E; Denig P
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1395-1405. PubMed ID: 37524658
[TBL] [Abstract][Full Text] [Related]
26. Unveiling Novel Markers and Modeling Clinical Prediction of Treatment Effects Are Equally Important for Implementing Precision Therapeutics.
Trischitta V; Menzaghi C; Copetti M
Diabetes; 2023 Aug; 72(8):1057-1059. PubMed ID: 37471601
[No Abstract] [Full Text] [Related]
27. Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.
Kennedy OJ; Kicinski M; Valpione S; Gandini S; Suciu S; Blank CU; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Boers-Sonderen M; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; van Akkooi ACJ; Robert C; Eggermont AMM; Lorigan P; Mandala M
Eur J Cancer; 2023 Aug; 189():112900. PubMed ID: 37277264
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome.
Nazirudeen R; Sridhar S; Priyanka R; Sumathi B; Natarajan V; Subbiah E; Raghavan KS; Sangumani J
Clin Endocrinol (Oxf); 2023 Aug; 99(2):198-205. PubMed ID: 37265016
[TBL] [Abstract][Full Text] [Related]
29. Metformin promotes Schwann cell remyelination, preserves neural tissue and improves functional recovery after spinal cord injury.
Huang Z; Lin J; Jiang H; Lin W; Huang Z; Chen J; Xiao W; Lin Q; Wang J; Wen S; Zhu Q; Liu J
Neuropeptides; 2023 Aug; 100():102348. PubMed ID: 37236132
[TBL] [Abstract][Full Text] [Related]
30. The safe use of metformin in heart failure patients both with and without T2DM: A cross-sectional and longitudinal study.
Chowdhury G; Carland JE; Kumar S; Olsen N; Graham G; Kumarasinghe G; Hayward CS; Greenfield JR; Macdonald P; Day RO; Stocker SL
Br J Clin Pharmacol; 2023 Aug; 89(8):2603-2613. PubMed ID: 37016750
[TBL] [Abstract][Full Text] [Related]
31. Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes.
Dunvald AD; Nielsen F; Olsen DA; Ernst MT; Donnelly L; Soto-Pedre E; Kristiansen MR; Nielsen JS; Persson F; Højlund K; Madsen JS; Søndergaard J; Pearson E; Pottegård A; Stage TB
Br J Clin Pharmacol; 2023 Aug; 89(8):2529-2541. PubMed ID: 36967527
[TBL] [Abstract][Full Text] [Related]
32. Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical Cohort.
Wancewicz B; Zhu Y; Fenske RJ; Weeks AM; Wenger K; Pabich S; Daniels M; Punt M; Nall R; Peter DC; Brasier A; Cox ED; Davis DB; Ge Y; Kimple ME
J Pharmacol Exp Ther; 2023 Aug; 386(2):169-180. PubMed ID: 36918276
[TBL] [Abstract][Full Text] [Related]
33. Metformin for the Treatment of Recurrent Respiratory Papillomatosis.
Din-Lovinescu C; Blitzer A
Ann Otol Rhinol Laryngol; 2023 Aug; 132(8):970-975. PubMed ID: 36131550
[TBL] [Abstract][Full Text] [Related]
34. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
Eur J Endocrinol; 2023 Aug; 189(2):S37-S63. PubMed ID: 37536294
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-graphene oxide quantum dots nanoconjugate as dual purpose drug delivery and therapeutic agent in meta-inflammation.
Sarkar K; Bank S; Chatterjee A; Dutta K; Das A; Chakraborty S; Paul N; Sarkar J; De S; Ghosh S; Acharyya K; Chattopadhyay D; Das M
J Nanobiotechnology; 2023 Aug; 21(1):246. PubMed ID: 37528408
[TBL] [Abstract][Full Text] [Related]
36. Influence of rutin and its combination with metformin on vascular functions in type 1 diabetes.
David SR; Lai PPN; Chellian J; Chakravarthi S; Rajabalaya R
Sci Rep; 2023 Aug; 13(1):12423. PubMed ID: 37528147
[TBL] [Abstract][Full Text] [Related]
37. Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy.
Zhang Y; Vandestienne M; Lavillegrand JR; Joffre J; Santos-Zas I; Lavelle A; Zhong X; Le Goff W; Guérin M; Al-Rifai R; Laurans L; Bruneval P; Guérin C; Diedisheim M; Migaud M; Puel A; Lanternier F; Casanova JL; Cochain C; Zernecke A; Saliba AE; Mokry M; Silvestre JS; Tedgui A; Mallat Z; Taleb S; Lenoir O; Vindis C; Camus SM; Sokol H; Ait-Oufella H
Nat Commun; 2023 Aug; 14(1):4622. PubMed ID: 37528097
[TBL] [Abstract][Full Text] [Related]
38. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression.
Ghorbanzadeh F; Jafari-Gharabaghlou D; Dashti MR; Hashemi M; Zarghami N
Med Oncol; 2023 Jul; 40(9):255. PubMed ID: 37515667
[TBL] [Abstract][Full Text] [Related]
39. Prescription of oral antidiabetics in Mexico. A cross-sectional study.
Fierro I; Gallardo-Mora O; Alba-Leonel A; Carvajal A; Molina-Guarneros JA
PLoS One; 2023; 18(7):e0288699. PubMed ID: 37498817
[TBL] [Abstract][Full Text] [Related]
40. Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups.
Gunay YE; Kişioğlu SV; Karakullukçu S; Tufekcı D; Demır AS; Coskun H; Nuhoglu I; Kocak M; Ersöz HÖ
Rev Assoc Med Bras (1992); 2023; 69(7):e20230174. PubMed ID: 37466599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
